429 filings
Page 20 of 22
8-K
vhcyz2 hl
4 Feb 15
ContraVir Pharmaceuticals’ HBV Compound CMX157 Receives Extended Patent Life
12:00am
8-K
1v4sgi7e8cxxl63plso3
20 Jan 15
ContraVir Pharmaceuticals Adds Carol L. Brosgart, M.D., to Scientific Advisory Board
12:00am
8-K
4zga4oxds5z
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
8-K
uk7lp5uz0hlxfe4a 74
8 Jan 15
ContraVir Pharmaceuticals adds Renu Gupta, M.D., to Scientific Advisory Board
12:00am
8-K
lbmgqvkrx4ffl9c8gkdg
7 Jan 15
ContraVir Pharmaceuticals Granted FDA Meeting to Discuss Proposal for Phase 3 Trial of FV-100
12:00am
8-K
edd uevni
18 Dec 14
Chimerix and ContraVir Pharmaceuticals Establish Strategic Collaboration for Antiviral Drug Candidate CMX157
12:00am
8-K
74oemw7opg5f dh20vb
16 Dec 14
ContraVir Pharmaceuticals Appoints Nathaniel Katz, M.D., Chairman of New Scientific Advisory Board Chair
12:00am
8-K
9izzay9wk62le
11 Dec 14
Other Events
12:00am
8-K
0aw1yvsp33jdggu1tl2
9 Dec 14
Other Events
12:00am
8-K
5wog8 avd0
2 Dec 14
Submission of Matters to a Vote of Security Holders
12:00am
10-K/A
t4pf8u8y73y132tfkz0
7 Nov 14
Annual report (amended)
12:00am
DEF 14A
p8d9vm5t
27 Oct 14
Definitive proxy
12:00am
UPLOAD
pc14 fnhc
27 Oct 14
Letter from SEC
12:00am
D
zdx19
23 Oct 14
$12.5M in equity, sold $9M, 1 investor
12:00am
PRER14A
apug942dv2fo8f 5sv
23 Oct 14
Preliminary revised proxy
12:00am
UPLOAD
y6i44p0371kq 6z4v
23 Oct 14
Letter from SEC
12:00am